• Fri. Jun 11th, 2021

Dengue

  • Home
  • Japan’s Takeda Pharmaceutical Plans to Submit Regulatory Filings for its Dengue vaccine in Sri Lanka this year

Japan’s Takeda Pharmaceutical Plans to Submit Regulatory Filings for its Dengue vaccine in Sri Lanka this year

Takeda Pharmaceutical Company Limited today announced that the European Medicines Agency (EMA) has accepted the Company’s filing packages for its dengue vaccine candidate (TAK-003) which is being investigated for the…